APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intermediate Bulk Container (IBC) for Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intermediate Bulk Container (IBC) for Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025188 pages

Choose your research edition.

Industry ResearchIntermediate Bulk Container (IBC) for Pharmaceutical Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Intermediate Bulk Container (IBC) for Pharmaceutical Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Intermediate Bulk Container (IBC) for Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intermediate Bulk Container (IBC) for Pharmaceutical Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Intermediate Bulk Container (IBC) for Pharmaceutical Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Intermediate Bulk Container (IBC) for Pharmaceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intermediate Bulk Container (IBC) for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intermediate Bulk Container (IBC) for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intermediate Bulk Container (IBC) for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intermediate Bulk Container (IBC) for Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intermediate Bulk Container (IBC) for Pharmaceutical include Matcon, KIT Co,ltd, THIELMANN, GEA, Dec Group, SCHÄFER Werke GmbH, Premier Tech Ltd., Ingredient Batching Systems Ltd and ISL Asia Technologies Pte. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intermediate Bulk Container (IBC) for Pharmaceutical market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intermediate Bulk Container (IBC) for Pharmaceutical and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intermediate Bulk Container (IBC) for Pharmaceutical sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intermediate Bulk Container (IBC) for Pharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.

Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Company

Matcon

KIT Co,ltd

THIELMANN

GEA

Dec Group

SCHÄFER Werke GmbH

Premier Tech Ltd.

Ingredient Batching Systems Ltd

ISL Asia Technologies Pte. Ltd.

Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Type

Stainless Steel IBC

Polyethylene IBC

Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Application

Tablet & Capsules

Powders

Ointments

Others

Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intermediate Bulk Container (IBC) for Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intermediate Bulk Container (IBC) for Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intermediate Bulk Container (IBC) for Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intermediate Bulk Container (IBC) for Pharmaceutical market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intermediate Bulk Container (IBC) for Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intermediate Bulk Container (IBC) for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intermediate Bulk Container (IBC) for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intermediate Bulk Container (IBC) for Pharmaceutical Industry Trends Table 2. Intermediate Bulk Container (IBC) for Pharmaceutical Industry Drivers Table 3. Intermediate Bulk Container (IBC) for Pharmaceutical Industry Opportunities and Challenges Table 4. Intermediate Bulk Container (IBC) for Pharmaceutical Industry Restraints Table 5. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Manufacturers Table 9. Global Intermediate Bulk Container (IBC) for Pharmaceutical Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Intermediate Bulk Container (IBC) for Pharmaceutical Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intermediate Bulk Container (IBC) for Pharmaceutical Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intermediate Bulk Container (IBC) for Pharmaceutical Manufacturers, Product Type & Application Table 13. Global Intermediate Bulk Container (IBC) for Pharmaceutical Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intermediate Bulk Container (IBC) for Pharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Stainless Steel IBC Table 17. Major Manufacturers of Polyethylene IBC Table 18. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2021-2026) & (k units) Table 20. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2027-2032) & (k units) Table 21. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Type (2021-2026) Table 22. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Type (2027-2032) Table 23. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2021-2026) & (k units) Table 25. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2027-2032) & (k units) Table 26. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Type (2021-2026) Table 27. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Tablet & Capsules Table 29. Major Manufacturers of Powders Table 30. Major Manufacturers of Ointments Table 31. Major Manufacturers of Others Table 32. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2021-2026) & (k units) Table 34. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2027-2032) & (k units) Table 35. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Application (2021-2026) Table 36. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Application (2027-2032) Table 37. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2021-2026) & (k units) Table 39. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2027-2032) & (k units) Table 40. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Application (2021-2026) Table 41. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Application (2027-2032) Table 42. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region (2021-2026) & (k units) Table 44. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Region (2021-2026) Table 45. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2026) & (k units) Table 49. North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2027-2032) & (k units) Table 50. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2026) & (k units) Table 52. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2027-2032) & (k units) Table 59. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Region (2021-2026) Table 63. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Region (2027-2032) Table 64. Matcon Company Information Table 65. Matcon Business Overview Table 66. Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 68. Matcon Recent Development Table 69. KIT Co,ltd Company Information Table 70. KIT Co,ltd Business Overview Table 71. KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 73. KIT Co,ltd Recent Development Table 74. THIELMANN Company Information Table 75. THIELMANN Business Overview Table 76. THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 78. THIELMANN Recent Development Table 79. GEA Company Information Table 80. GEA Business Overview Table 81. GEA Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GEA Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 83. GEA Recent Development Table 84. Dec Group Company Information Table 85. Dec Group Business Overview Table 86. Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 88. Dec Group Recent Development Table 89. SCHÄFER Werke GmbH Company Information Table 90. SCHÄFER Werke GmbH Business Overview Table 91. SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 93. SCHÄFER Werke GmbH Recent Development Table 94. Premier Tech Ltd. Company Information Table 95. Premier Tech Ltd. Business Overview Table 96. Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 98. Premier Tech Ltd. Recent Development Table 99. Ingredient Batching Systems Ltd Company Information Table 100. Ingredient Batching Systems Ltd Business Overview Table 101. Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 103. Ingredient Batching Systems Ltd Recent Development Table 104. ISL Asia Technologies Pte. Ltd. Company Information Table 105. ISL Asia Technologies Pte. Ltd. Business Overview Table 106. ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio Table 108. ISL Asia Technologies Pte. Ltd. Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Intermediate Bulk Container (IBC) for Pharmaceutical Distributors List Table 112. Intermediate Bulk Container (IBC) for Pharmaceutical Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Intermediate Bulk Container (IBC) for Pharmaceutical Product Image Figure 2. Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales (2021-2032) & (k units) Figure 5. Global Intermediate Bulk Container (IBC) for Pharmaceutical Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intermediate Bulk Container (IBC) for Pharmaceutical Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Stainless Steel IBC Image Figure 9. Polyethylene IBC Image Figure 10. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Type (2021-2032) Figure 13. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Type (2021-2032) Figure 16. Tablet & Capsules Image Figure 17. Powders Image Figure 18. Ointments Image Figure 19. Others Image Figure 20. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Application (2021-2032) Figure 23. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Application (2021-2032) Figure 26. North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Country (2021-2032) Figure 28. U.S. Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Country (2021-2032) Figure 33. Germany Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Country (2021-2032) Figure 40. China Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Country (2021-2032) Figure 48. Brazil Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032) & (US$ Million) Figure 59. North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032) & (US$ Million) Figure 61. Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Intermediate Bulk Container (IBC) for Pharmaceutical Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Intermediate Bulk Container (IBC) for Pharmaceutical Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Stainless Steel IBC
  • Polyethylene IBC
Applications
  • Tablet & Capsules
  • Powders
  • Ointments
  • Others
Companies covered
  • Matcon
  • KIT Co,ltd
  • THIELMANN
  • GEA
  • Dec Group
  • SCHÄFER Werke GmbH
  • Premier Tech Ltd.
  • Ingredient Batching Systems Ltd
  • ISL Asia Technologies Pte. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Dynamics
  1. 2.1 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Trends
  2. 2.2 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Drivers
  3. 2.3 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Restraints
3 Intermediate Bulk Container (IBC) for Pharmaceutical Market by Manufacturers
  1. 3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intermediate Bulk Container (IBC) for Pharmaceutical Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intermediate Bulk Container (IBC) for Pharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intermediate Bulk Container (IBC) for Pharmaceutical Manufacturers, Product Type & Application
  7. 3.7 Global Intermediate Bulk Container (IBC) for Pharmaceutical Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intermediate Bulk Container (IBC) for Pharmaceutical Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intermediate Bulk Container (IBC) for Pharmaceutical Tier 1, Tier 2, and Tier 3
4 Intermediate Bulk Container (IBC) for Pharmaceutical Market by Type
  1. 4.1 Intermediate Bulk Container (IBC) for Pharmaceutical Type Introduction
  2. 4.1.1 Stainless Steel IBC
  3. 4.1.2 Polyethylene IBC
  4. 4.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type
  5. 4.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2021-2032)
  7. 4.2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Type (2021-2032)
  8. 4.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type
  9. 4.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2021-2032)
  11. 4.3.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Type (2021-2032)
5 Intermediate Bulk Container (IBC) for Pharmaceutical Market by Application
  1. 5.1 Intermediate Bulk Container (IBC) for Pharmaceutical Application Introduction
  2. 5.1.1 Tablet & Capsules
  3. 5.1.2 Powders
  4. 5.1.3 Ointments
  5. 5.1.4 Others
  6. 5.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application
  7. 5.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2021-2032)
  9. 5.2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Application (2021-2032)
  10. 5.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application
  11. 5.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2021-2032)
  13. 5.3.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Application (2021-2032)
6 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region
  1. 6.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region (2021-2032)
  3. 6.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region (2021-2026)
  4. 6.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region
  1. 7.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region
  2. 7.1.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2021-2026)
  4. 7.1.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region (2027-2032)
  5. 7.1.4 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032)
  8. 7.2.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032)
  11. 7.3.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Matcon
  2. 8.1.1 Matcon Company Information
  3. 8.1.2 Matcon Business Overview
  4. 8.1.3 Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  6. 8.1.5 Matcon Recent Developments
  7. 8.2 KIT Co,ltd
  8. 8.2.1 KIT Co,ltd Company Information
  9. 8.2.2 KIT Co,ltd Business Overview
  10. 8.2.3 KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  12. 8.2.5 KIT Co,ltd Recent Developments
  13. 8.3 THIELMANN
  14. 8.3.1 THIELMANN Company Information
  15. 8.3.2 THIELMANN Business Overview
  16. 8.3.3 THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  18. 8.3.5 THIELMANN Recent Developments
  19. 8.4 GEA
  20. 8.4.1 GEA Company Information
  21. 8.4.2 GEA Business Overview
  22. 8.4.3 GEA Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GEA Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  24. 8.4.5 GEA Recent Developments
  25. 8.5 Dec Group
  26. 8.5.1 Dec Group Company Information
  27. 8.5.2 Dec Group Business Overview
  28. 8.5.3 Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  30. 8.5.5 Dec Group Recent Developments
  31. 8.6 SCHÄFER Werke GmbH
  32. 8.6.1 SCHÄFER Werke GmbH Company Information
  33. 8.6.2 SCHÄFER Werke GmbH Business Overview
  34. 8.6.3 SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  36. 8.6.5 SCHÄFER Werke GmbH Recent Developments
  37. 8.7 Premier Tech Ltd.
  38. 8.7.1 Premier Tech Ltd. Company Information
  39. 8.7.2 Premier Tech Ltd. Business Overview
  40. 8.7.3 Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  42. 8.7.5 Premier Tech Ltd. Recent Developments
  43. 8.8 Ingredient Batching Systems Ltd
  44. 8.8.1 Ingredient Batching Systems Ltd Company Information
  45. 8.8.2 Ingredient Batching Systems Ltd Business Overview
  46. 8.8.3 Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  48. 8.8.5 Ingredient Batching Systems Ltd Recent Developments
  49. 8.9 ISL Asia Technologies Pte. Ltd.
  50. 8.9.1 ISL Asia Technologies Pte. Ltd. Company Information
  51. 8.9.2 ISL Asia Technologies Pte. Ltd. Business Overview
  52. 8.9.3 ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
  54. 8.9.5 ISL Asia Technologies Pte. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intermediate Bulk Container (IBC) for Pharmaceutical Value Chain Analysis
  2. 9.1.1 Intermediate Bulk Container (IBC) for Pharmaceutical Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intermediate Bulk Container (IBC) for Pharmaceutical Production Mode & Process
  6. 9.2 Intermediate Bulk Container (IBC) for Pharmaceutical Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intermediate Bulk Container (IBC) for Pharmaceutical Distributors
  9. 9.2.3 Intermediate Bulk Container (IBC) for Pharmaceutical Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst